Invention Application
![Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient](/docs/US/2020-02-06/US20200039984A1/abs.jpg.600x600.jpg)
- Patent Title: Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient
-
Application No.: US16480908Application Date: 2018-01-25
-
Publication No.: US20200039984A1Publication Date: 2020-02-06
- Inventor: Kwangho Lee , Gildon Choi , Imran Ali , Joo Yun Lee , Jin Soo Lee , Whui Jung Park , Yong Tae Kim , Seung Hwan Kim , Jung Hwan Kim , Jae-Kyung Lim
- Applicant: Dong Wha Pharm. Co., Ltd. , Korea Research Institute of Chemical Technology
- Priority: KR10-2017-0012823 20170126
- International Application: PCT/KR2018/001128 WO 20180125
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D519/00 ; A61P35/00
![Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient](/abs-image/US/2020/02/06/US20200039984A1/abs.jpg.150x150.jpg)
Abstract:
Provided are a novel [1,2,4]triazolo[4,3-a]quinoxaline derivative, a method for preparing the same, and a pharmaceutical composition for preventing or treating bromodomain extra-terminal (BET) protein-related diseases including cancer and autoimmune diseases, containing the same as an active ingredient.
Public/Granted literature
Information query
